Bluejay Diagnostics CEO Buys 28,000 Shares Amid 81% Stock Decline — Insider Confidence or Speculative Gamble?
Bluejay Diagnostics insider buying: CEO Dey Indranil’s 28,000‑share RSU purchase signals confidence amid a steep price decline. Explore what it means for investors and potential turnaround.
3 minutes to read

